FindMyRecallSubscribe
Class II: temporary or reversible health riskOngoing

Apollo Care FentaNYL 500mcg Recall

FentaNYL 500mcg (2mcg/mL) and Ropivacaine HCl 250mg (0

Apollo Care, LLC · Columbia, MO

Risk level
Class II
Reported by FDA
May 14, 2025
Recall ID
D-0409-2025
Check your lot numberHow we source this data

Summary

Apollo Care recalled FentaNYL 500mcg starting Apr 15, 2025. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0409-2025 on May 14, 2025. Reason: Lack of Assurance of Sterility. Status: Ongoing.

Why it was recalled

Lack of Assurance of Sterility

Product description

FentaNYL 500mcg (2mcg/mL) and Ropivacaine HCl 250mg (0.1%) added to 250 mL, 0.9% Sodium Chloride Injection (For Epidural Use Only), Sterile, Single-Use Container, Rx Only, Apollocare, 3801 Mojave Ct, Ste 101, Columbia, MO 65202, NDC 71170-950-25

Lot numbers, UPCs & expiration codes

Lot AC-016878, exp date 6/16/2025

Where it was sold

MO

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0409-2025
Classification
Class II
Status
Ongoing
Recall initiated
Apr 15, 2025
FDA report date
May 14, 2025
Quantity
440 bags
Recall type
Voluntary: Firm initiated
Recalling firm
Apollo Care, LLC

Original FDA data

Every field from FDA enforcement report D-0409-2025, exactly as published.

Show all FDA fields
City
Columbia
State
MO
Status
Ongoing
Country
United States
Event ID
96754
Address
3801 Mojave Ct Ste 101
Code information
Lot AC-016878, exp date 6/16/2025
Postal code
65202-4042
Report date
May 14, 2025
Product type
Drugs
Recall number
D-0409-2025
Classification
Class II
Recalling firm
Apollo Care, LLC
Product quantity
440 bags
Reason for recall
Lack of Assurance of Sterility
Voluntary / mandated
Voluntary: Firm initiated
Product description
FentaNYL 500mcg (2mcg/mL) and Ropivacaine HCl 250mg (0.1%) added to 250 mL, 0.9% Sodium Chloride Injection (For Epidural Use Only), Sterile, Single-Use Container, Rx Only, Apollocare, 3801 Mojave Ct, Ste 101, Columbia, MO 65202, NDC 71170-950-25
Distribution pattern
MO
Recall initiation date
Apr 15, 2025
Initial firm notification
Letter
Center classification date
May 6, 2025

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0409-2025, published May 14, 2025. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls